MedQuist Holdings Inc. Announces Senior Management Team Additions to Lead the Integration of M*Modal
September 06 2011 - 6:45AM
MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of
integrated clinical documentation solutions for the U.S. healthcare
system, announced additions to the senior management team as a
result of the merger with M*Modal.
The new additions to the team include Michael Finke as
President, Juergen Fritsch as Chief Scientist, Detlef Koll as Chief
Technology Officer and Ronald Scarboro as Chief Financial Officer.
Mr. Scarboro is replacing Tony James, who has resigned to pursue an
opportunity with a private healthcare company. Mr. James will stay
until October 1, 2011, to assist with the transition.
Mr. Scarboro, who has been with the Company since August 15,
2011, as Senior Financial Executive, has 20 years of technology and
healthcare industry experience in finance and accounting, investor
relations and acquisitions. Most recently, he held the position of
Chief Financial Officer, Strategic Diversification at Aetna, Inc.
Prior to Aetna, Ron held executive positions in finance and
strategic operations with Allscripts, Misys Healthcare, The
Trizetto Group, Verian Technologies, A4 Health Systems and other
companies. He holds a BA degree from North Carolina State
University and is a Certified Public Accountant.
Mr. Finke, who was previously Chairman, CEO and Co-Founder of
M*Modal, will lead the Company's strategic account development,
joint innovation and collaboration with healthcare provider
organizations, and partnerships with healthcare IT and services
companies, as well as industry thought leadership. A respected
technology leader in the field of conversational speech recognition
and natural language understanding, Mr. Finke has led M*Modal from
inception in 2001 to its industry leadership role and large scale
adoption of its unique cloud based natural language understanding
services. Prior to M*Modal, Mr. Finke served as Chief Technology
Officer and a Co-Founder of Interactive Systems (ISI) and has held
positions at IBM, the University of Karlsruhe and Carnegie Mellon
University. He has published more than 30 articles and earned his
B.Eng. and M.Eng. degrees in computer science from the University
of Karlsruhe, Germany.
Dr. Fritsch was previously Chief Scientist and Co-Founder of
M*Modal and will be responsible for core research and innovations.
At M*Modal, he was instrumental in growing the company's IP
portfolio and establishing its leadership role in the field of
conversational speech understanding. Before founding M*Modal, he
was one of the founders of ISI, where he served as Principal
Research Scientist and was responsible for developing a next
generation medical speech understanding system. Dr. Fritsch held
research positions at the University of Karlsruhe and at Carnegie
Mellon University. He has published more than 20 papers and has
been granted numerous patents on various speech recognition and
natural language processing aspects relevant to the healthcare
domain. He earned his M.Sc. and Ph.D. degrees in computer science
from the University of Karlsruhe.
Mr. Koll, who was previously Chief Technology Officer and
Co-Founder of M*Modal, will lead product development activities
across the entire organization. At M*Modal, he was the driving
force in the development of its Conversational Documentation
Services platform and established M*Modal as the leading technology
partner in the healthcare documentation space. Before founding
M*Modal, he was a Co-Founder and Vice President for product
development for ISI and served as Director of Speech Recognition
Research at Lernout & Hauspie Speech Products. He has held
research positions at Carnegie Mellon University and Advanced
Telecommunications Research Laboratories in Kyoto, Japan. He earned
his B.Eng. and M.Eng. degrees in computer science from the
University of Karlsruhe.
Vern Davenport, Chairman and Chief Executive Officer of MedQuist
Holdings, noted, "We've previously outlined aggressive plans to
bring MedQuist and M*Modal together and align the resources between
our two companies. The additions of Michael, Juergen, Detlef and
Ron to the senior leadership team address the specific needs we
identified in strategic account and partnerships, product
development and organizational structure. I have tremendous respect
for the talent and capabilities of this team. We all are aligned
with executing on the opportunities we have to provide
technology-enabled solutions to address the challenges facing our
healthcare industry.
"We respect Tony's decision to return to the private arena and
thank him for his many contributions to our company. He has played
an integral role in our integration of Spheris and MedQuist as well
as the acquisition of M*Modal. Ron had been brought on board to
lead our internal strategic programs and organizational
transformation. Ron will now be responsible for all financial
operations of MedQuist, a role that he has executed well throughout
his career."
About MedQuist Holdings
MedQuist Holdings is a leading provider of medical transcription
services, and a leader in technology-enabled clinical documentation
workflow. MedQuist's enterprise solutions – including mobile voice
capture devices, speech recognition, Web-based workflow platforms,
and global network of medical editors – help healthcare facilities
improve patient care, increase physician satisfaction, and lower
operational costs. For more information, please visit
www.medquist.com.
The MedQuist Holdings Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10083
Forward-Looking Statements
Information provided and statements contained in this press
release that are not purely historical, such as
statements regarding the integration of M*Modal, are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act
of 1934 and the Private Securities Litigation Reform Act of 1995.
Such forward-looking statements only speak as of the date of this
press release and MedQuist Holdings Inc. assumes no obligation to
update the information included in this press release. Statements
made in this press release that are forward-looking in nature may
involve risks and uncertainties. Accordingly, readers are cautioned
that any such forward-looking statements are not guarantees of
future performance and are subject to certain risks, uncertainties
and assumptions that are difficult to predict, including, without
limitation, specific factors discussed herein and in other releases
and public filings made by MedQuist Holdings Inc. (including
filings by MedQuist Holdings Inc. with the SEC). Although MedQuist
Holdings believes that the expectations reflected in such
forward-looking statements are reasonable as of the date made,
expectations may prove to have been materially different from the
results expressed or implied by such forward-looking statements.
Unless otherwise required by law, MedQuist Holdings also disclaims
any obligation to update its view of any such risks or
uncertainties or to announce publicly the result of any revisions
to the forward-looking statements made in this press release.
CONTACT: Investor Contacts:
Ron Scarboro
Chief Financial Officer
ronald.scarboro@medquist.com
(615) 798-4350
Tripp Sullivan
Corporate Communications, Inc.
tripp.sullivan@cci-ir.com
(615) 324-7335
Media Contact:
Thomas Mitchell
Director of Marketing
tmitchell@medquist.com
(615) 798-6630
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024